Otsuka group is a global company committed to improving people's health worldwide, and we have established a governance structure that strives to create a sustainable society by minimizing its impact on the environment through its core businesses. The Otsuka Holdings Environmental Committee, consisting of the Executive Deputy President and representatives from group companies, determines the environmental policies and initiatives. These decisions are then approved by the Board of Directors and shared with the operating companies under the Otsuka group as the group's response policy.

Otsuka Pharmaceutical has set up the Otsuka Pharmaceutical Environmental and Social Committee, which creates targets and implementation plans aligned with the group's environmental policy and business activities. The Environmental Subcommittee discusses specific initiatives, which are then tailored to each business site's characteristics by the Environmental Promotion Committee.

To achieve sustainable development in an environmentally friendly way, Otsuka regularly evaluates the results of its initiatives, holds discussions to address issues, and incorporates the outcomes into company-wide promotion plans.

Otsuka Pharmaceutical is committed to reducing the environmental impact and managing environmental risks associated with its corporate activities. To achieve this, it has established a system appropriate to the size of the impact of each type of work. Seven plants and major research facilities in Japan have obtained ISO 14001 certification, while sales operations sites have implemented and are continually improving environmental management systems based on ISO 14001. The Tokushima Mima Factory, which commenced operations in 2020, is also preparing to obtain ISO 14001 certification. In August 2020, the Otsuka group obtained an integrated ISO 14001 certification, strengthening its environmental governance. All business sites within the Otsuka group strive for sustainable development by complying with ISO 14001 standards.